Thomas S Dexheimer
6PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 19, 2026
Endosialin (CD248) Cancer Role and Therapeutics: 33 Years on.Beverly A Teicher, Li Chen, Dianne L Newton
|Sep 17, 2025
RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types.Zahra Davoudi, Thomas S Dexheimer, Nathan P Coussens
|Jun 11, 2024
HTS384 NCI60: The Next Phase of the NCI60 Screen.Mark W Kunkel, Nathan P Coussens, Joel Morris
|Aug 28, 2023
Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs.Thomas S Dexheimer, Nathan P Coussens, Thomas Silvers
|Aug 07, 2023
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource.Joel Morris, Mark W Kunkel, Stephen L White
|Feb 16, 2018
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.William C Stafford, Xiaoxiao Peng, Maria Hägg Olofsson
Pageof 1
Frequent Collaborators
6 joint publications
Nathan P Coussens
5 joint publications
Beverly A Teicher
5 joint publications
James H Doroshow
4 joint publications
Joel Morris
2 joint publications
Thomas Silvers
2 joint publications
Melinda G Hollingshead
2 joint publications
Mark W Kunkel
1 joint publications
Diane K Luci
1 joint publications
Lionel Trésaugues
1 joint publications
Martin Augsten
